In this volume 8 of the Cardiovascular Genomics Insights, we discuss the role of genetics in the management of ARVC patients, with the contribution of Professor Kristina Haugaa (Oslo University Hospital, Rikshospitalet, Norway). This content highlights the impact of the 2023 ESC Guidelines on cardiomyopathy on the care of patients, including children.
Prescribe exercise in patients with arrhythmogenic right ventricular cardiomyopathy
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy (ARVC)
ARVC Quiz based on the 2023 ESC Guidelines for Cardiomyopathies
Our mission: To reduce the burden of cardiovascular disease.